000 | 01854 a2200505 4500 | ||
---|---|---|---|
005 | 20250515131856.0 | ||
264 | 0 | _c20081006 | |
008 | 200810s 0 0 eng d | ||
022 | _a1550-6606 | ||
024 | 7 |
_a10.4049/jimmunol.181.4.2563 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Witte, Moniek A | |
245 | 0 | 0 |
_aTCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation. _h[electronic resource] |
260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cAug 2008 |
||
300 |
_a2563-71 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenocarcinoma _xgenetics |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, Viral, Tumor _xbiosynthesis |
650 | 0 | 4 | _aClone Cells |
650 | 0 | 4 |
_aImmunotherapy, Adoptive _xmethods |
650 | 0 | 4 |
_aInfluenza A virus _ximmunology |
650 | 0 | 4 |
_aLymphocyte Activation _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aProstatic Neoplasms _xgenetics |
650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xadministration & dosage |
650 | 0 | 4 |
_aSimian virus 40 _ximmunology |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aTransduction, Genetic _xmethods |
650 | 0 | 4 |
_aVaccinia _ximmunology |
700 | 1 | _aBendle, Gavin M | |
700 | 1 | _avan den Boom, Marly D | |
700 | 1 | _aCoccoris, Miriam | |
700 | 1 | _aSchell, Todd D | |
700 | 1 | _aTevethia, Satvir S | |
700 | 1 | _avan Tinteren, Harm | |
700 | 1 | _aMesman, Elly M | |
700 | 1 | _aSong, Ji-Ying | |
700 | 1 | _aSchumacher, Ton N M | |
773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 181 _gno. 4 _gp. 2563-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4049/jimmunol.181.4.2563 _zAvailable from publisher's website |
999 |
_c18159559 _d18159559 |